RNA modification has recently become a significant process of gene regulation, and the
methyltransferase-like (METTL) family of proteins plays a critical role in RNA modification …

Lung cancer, a highly malignant disease, greatly affects patients' quality of life. N6-
methyladenosine (m6A) is one of the most common posttranscriptional modifications of …

Non-small cell lung cancer is the leading cause of cancer related mortality worldwide, and
lung adenocarcinoma (LUAD) is one of the most common subtypes. The role of N6 …

Abstract N6-methyladenosine (m6A), one of the most common RNA methylation
modifications, has emerged in recent years as a new layer of the regulatory mechanism …

Abstract N6-methyladenosine (m6A) methylation, the most prevalent and abundant RNA
modification in eukaryotes, has recently become a hot research topic. Several studies have …

Marvelous advancements have been made in cancer therapies to improve clinical outcomes
over the years. However, therapeutic resistance has always been a major difficulty in cancer …

Drug resistance is perhaps the greatest obstacle in improving outcomes for cancer patients,
leading to recurrence, progression and metastasis of various cancers. Exploring the …

Long noncoding RNAs (lncRNAs) play an important role in tumor progression. Small
nucleolar RNA host gene 15 (SNHG15) is a lncRNA that has been confirmed to play an …

Background As one of the most ubiquitous types of posttranscriptional modification, N6-
methyladenosine (m6A) is extensively implicated in almost all types of cancers, including …

As one of the most abundant epigenetic modifications in RNA, N6-methyladenosine (m6A)
affects RNA transcription, splicing, stability, and posttranscriptional translation …